Rapid and sustained control of itch and reduction in Th2 bias by dupilumab in a patient with Sézary syndromeOliver Steck, Christoph Schlapbach, Andreas Holbro et al.|Journal of the European Academy of Dermatology and Venereology|2020Cited by 39